🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jason Hafron

Oakland University

ORCID: 0000-0003-0866-797X

Also affiliated with Michigan Institute of Urology, Beaumont Hospital, Royal Oak, Royal Oak Community Coalition

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626885
Top 100%
0DataRank
Top 100%0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Papers

Driven by 6 papers — median percentile 0. Top paper: “Comprehensive proteogenomic characterization of rare kidney tumors”.

Comprehensive proteogenomic characterization of rare kidney tumors

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101547
N/A
0.920DataRank · unranked
46 citations

Lijun Chen, Yi Hsiao, Rahul Mannan, Yuping Zhang, Jie Luo +95 more

Detection of Germline Variants in Patients With Localized and Metastatic Prostate Cancer Through Guideline-Based Testing

Urology Practice(2024)10.1097/upj.0000000000000727
N/A
0DataRank · unranked
2 citations

Marissa A. Solorzano, Jake Quarles, Mallory Luke, Milan Patel, Randy Vince +15 more

Intravesical local administration of pembrolizumab for treatment of bladder cancer: A novel strategy to minimize toxicity.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.e14687
N/A
0DataRank · unranked
0 citations

Anirban Ganguly, Jason Hafron, Jonathan L. Kaufman, Michael B. Chancellor, Pradeep Tyagi

Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626876
N/A
0DataRank · unranked
0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.23626885
Top 100%
0DataRank
Top 100%0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more

Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

10.1158/1078-0432.c.6666732.v2
N/A
0DataRank · unranked
0 citations

Sumit K. Subudhi, Christopher Pieczonka, Lawrence I. Karsh, David I. Quinn, Jason Hafron +6 more